藏药帕栗嘎用药现状和品种整理研究

Study on the present situation and the varieties of the drug use of Tibetan medicine PA Li GA

藏药帕栗嘎在众多藏药传统复方药物中作为君、臣药已使用了近千年,藏医临床治疗中起到了很好的疗效。而近期藏药帕栗嘎产生几种代用品或误用品,以及其所含的马兜铃酸而被相关部门禁止使用或禁止载入药典,使藏医临床治疗方面受到了一定的限制。根据目前在尼泊尔、不丹、以及国内部分藏医院使用的帕栗嘎,以及其市场来源等之间均存在一定的差异。本文依据藏药传统辨认技术,结合与现代药用植物学、生药学等学科知识,通过本草考证、各家论述等方法,阐述了目前作为帕栗嘎入药的品种分为2科2属10种植物,且均为代用品或误用品,而《晶珠本草》所记载的正品帕栗嘎目前无统一辨认和入药。

Tibetan medicine PA Li GA in many traditional Tibetan medicine compound drugs as Jun, Chen medicine has been used nearly a thousand years, in the clinical therapy of Tibetan medicine plays a very good curative effect. And the recent Tibetan medicine PA Li GA several substitutes or misuse of activities, as well as the aristolochic acid and related departments to prohibit the use or prohibition load Pharmacopoeia, the Tibetan clinical treatment by certain restrictions. According to the present in Nepal, Bhutan, as well as the domestic part of the hospital＇s use of the Tibetan medicine, as well as its market sources, there are some differences between. This paper, on the basis of Tibetan traditional identification techniques and combining with modern pharmaceutical botany and pharmacognosy and other disciplines of knowledge, through the textual research, discusses various methods, this paper expounds the present as PA Li GA medicine varieties divided into 2 families, 2 genera and 10 species, and were as a substitute or misuse of the activities, and recorded in the Jingzhu Materia Medica ＂authentic PA Li GA there is no unified identification and medicine.